The following companies saw new developments that may affect trading of their securities on Friday (Nov 24):
CDL (C09): City Developments Ltd (CDL) and its joint venture associates increased third-quarter sales to S$325 million, from S$281 million in the year-ago period.
Over the same duration, they sold 183 units, up from 95 units a year earlier.
In its operational update on Thursday (Nov 23), CDL said that the improvement came on the back of the launch of The Myst, a 408-unit residential development located along Upper Bukit Timah Road.
LHN (41O): Real estate services provider LHN Group will transfer from the Catalist to the Singapore Exchange’s mainboard on Dec 13.
In a bourse filing on Thursday (Nov 23), the company said that trading in its shares will commence at 9 am that same day.
It added that the company’s appointment of Primepartners Corporate Finance as its continuing sponsor will cease on Dec 13.
Dasin Retail Trust (CEDU): A group of 15 Dasin Retail Trust investors, who collectively hold over 10 per cent of the units in the business trust, have served a requisition notice to replace its current external trustee-manager, Dasin Retail Trust Management (DRTM), with a newly incorporated internal trustee-manager. The new entity will be wholly owned by all unitholders of Dasin Retail Trust.
On behalf of this group, unitholder Tao Naiqun on Thursday (Nov 23) said that the minority investors were seeking to convene an extraordinary general meeting (EGM) to approve the internalisation “as a matter of urgency”.
This was because the trustee-manager’s major shareholder, Sino-Ocean Capital, remains subject to a creditors’ winding-up petition to be heard on Mar 27, 2024.
Clearbridge Health (1H3), Biolidics (8YY): Clearbridge Health is considering Biolidics’ proposal to repay its debt, which amounts to some S$2.1 million, by the extended deadline of Dec 23, 2023.
The medical technology (medtech) company on Wednesday (Nov 22) said it is also considering its options regarding Biolidics’ outstanding debt and will provide further updates in due course.
On Tuesday, Catalist-listed medtech company Biolidics proposed issuing 98.5 million new ordinary shares at S$0.0119 apiece to raise S$1.2 million from Zhu Hua, a China citizen who owns 99.9 per cent of China-based investment management company, Zhenghe Antai Investment Management.
NauticAWT (42D): DR CHIRASAK Chiyachantana, the non-independent non-executive chairman of Catalist-listed NauticAWT, resigned on Thursday (Nov 23) in light of a criminal complaint filed against him by the Securities and Exchange Commission, Thailand.
Aside from the complaint, NauticAWT said there were no other material reasons for his resignation.
He is also in the process of stepping down from the boards of two of NauticAWT’s subsidiaries in Thailand – World Industrial Estate and Chokdee Dimsum.
Comments